Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia.

Xiangyu Zhao Haotian Wu Yifei Cheng Zhengli Xu Yuhong Chen Yingjun Chang Yu Wang Xiaohui Zhang Lanping Xu Xiaojun Huang

Chin Med J (Engl)

Peking University People's Hospital, Peking University Institute of Hematology, Department of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Xicheng District, Beijing 100044, China.

Published: August 2023

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431388	PMC
http://dx.doi.org/10.1097/CM9.0000000000002764	DOI Listing

Publication Analysis

Top Keywords

bridging chimeric

chimeric antigen

antigen receptor

receptor t-cell

t-cell transplantation

transplantation improves

improves prognosis

prognosis relapsed/refractory

relapsed/refractory b-cell

b-cell acute

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!